Nitesh Kunda
Affiliations: | 2010-2011 | The School of Pharmacy | University of London, London, England, United Kingdom |
| 2018- | College of Pharmacy and Health Science | St. John's University, NY, United States |
Google:
"Nitesh Kunda"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kostas Kostarelos | grad student | 2010-2011 | University of London |
| Stephen Gordon | grad student | 2011-2014 | Liverpool School of Tropical Medicine |
| Gillian Hutcheon | grad student | 2011-2014 | Liverpool John Moores University |
| Imran Saleem | grad student | 2011-2014 | Liverpool John Moores University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Petkar KC, Patil SM, Chavhan SS, et al. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics. 13 |
| Alfagih IM, Kaneko K, Kunda NK, et al. (2021) In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers. Pharmaceuticals (Basel, Switzerland). 14 |
| Wang X, Parvathaneni V, Shukla SK, et al. (2020) Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules |
| Parvathaneni V, Kulkarni NS, Chauhan G, et al. (2020) Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC). Materials Science & Engineering. C, Materials For Biological Applications. 115: 111139 |
| Elbatanony RS, Parvathaneni V, Kulkarni NS, et al. (2020) Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy. Drug Delivery and Translational Research |
| Shukla SK, Kulkarni NS, Farrales P, et al. (2020) Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer. Pharmaceutical Research. 37: 67 |
| Vaidya B, Kulkarni NS, Shukla SK, et al. (2020) Development of Inhalable Quinacrine Loaded Bovine Serum Albumin Modified Cationic Nanoparticles: Repurposing Quinacrine for Lung Cancer Therapeutics. International Journal of Pharmaceutics. 118995 |
| Mohamed A, Kunda NK, Ross K, et al. (2019) Polymeric Nanoparticles for the Delivery of miRNA to Treat Chronic Obstructive Pulmonary Disease (COPD). European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Petkar KC, Chavhan S, Kunda N, et al. (2018) Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design. Aaps Pharmscitech |
| Rodrigues TC, Oliveira MLS, Soares-Schanoski A, et al. (2018) Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection. Plos One. 13: e0191692 |